Medical Condition News

RSS

Scientists use RNAi technology to reveal genes responsible for treating Parkinson's disease

Scientists at the National Institutes of Health have used RNA interference (RNAi) technology to reveal dozens of genes which may represent new therapeutic targets for treating Parkinson's disease. The findings also may be relevant to several diseases caused by damage to mitochondria, the biological power plants found in cells throughout the body.

24 Nov 2013

UT Dallas professor awarded $2.3 million NIH grant to continue prosthetics, orthotics research

Dr. Robert Gregg, an assistant professor of mechanical engineering and bioengineering who joined the Erik Jonsson School of Engineering and Computer Science this fall, is a recipient of a $2.3 million grant from the National Institutes of Health for research that will combine robot control theory and physical rehabilitation to revolutionize and improve prosthetic limbs and orthotic devices.

23 Nov 2013

CVD expert requests Mexican government to carry out mandatory screening for 18-year-olds

A cardiovascular disease expert is calling for mandatory screening of 18 year-old Mexicans to halt the CVD epidemic plaguing the nation. Cardiovascular risk factors will be a key theme at the Mexican Congress of Cardiology, held 23 to 27 November in Leon, Guanajuato, Mexico. The Congress is organised by the Mexican Society of Cardiology and features a collaborative programme with the European Society of Cardiology.

23 Nov 2013

Sorin Group receives CE Mark approval for Solo Smart stentless aortic valve

Sorin Group, a global medical company and a leader in the treatment of cardiovascular diseases, announced today that it has received CE Mark approval for the Solo Smart stentless aortic valve.

23 Nov 2013

EC approves INVOKANA (canagliflozin) medication for adults with type 2 diabetes mellitus

Janssen-Cilag International NV announced today that the European Commission has approved INVOKANA (canagliflozin) in the European Union for the treatment of adults with type 2 diabetes mellitus, to improve glycaemic control[1]. Canagliflozin is an oral, once-daily medication, which belongs to a new class of medications called sodium glucose co-transporter 2 (SGLT2) inhibitors.

23 Nov 2013

NEXAVAR tablets receive FDA approval for treatment of patients with thyroid cancer

Bayer HealthCare and Onyx Pharmaceuticals, Inc., an Amgen subsidiary, today announced that the U.S. Food and Drug Administration has approved a supplemental New Drug Application for the oral multi-kinase inhibitor NEXAVAR (sorafenib) tablets for the treatment of patients with locally recurrent or metastatic, progressive, differentiated thyroid carcinoma refractory to radioactive iodine treatment.

23 Nov 2013

Study highlights need for ongoing surveillance for melanoma survivors

Melanoma survivors are being warned to stay vigilant about skin checks, with new research showing a high risk of a subsequent melanoma diagnosis on the same body part as the original.

22 Nov 2013

Sinai Hospital reports results from Phase 2a trial of apo A-I infusion therapy CSL112

Researchers from the Sinai Center for Thrombosis Research presented findings from a Phase 2a trial substudy that examined the antiplatelet effects of CSL112, a novel apolipoprotein A-I (apo A-I) infusion therapy, at the American Heart Association 2013 Scientific Sessions.

22 Nov 2013

Genetic diagnostic test for inherited eye diseases now available from Mass. Eye and Ear

The Massachusetts Eye and Ear/Harvard Medical School Department of Ophthalmology today announced the availability of a comprehensive genetic diagnostic test for inherited eye diseases.

22 Nov 2013

Mouse study highlights importance of microorganisms in optimal cancer treatment outcomes

...

22 Nov 2013

Nanotechnology-based technique: A painless method for maintaining healthy blood sugar levels

A new nanotechnology-based technique for regulating blood sugar in diabetics may give patients the ability to release insulin painlessly using a small ultrasound device, allowing them to go days between injections - rather than using needles to give themselves multiple insulin injections each day.

22 Nov 2013

EYLEA Injection gets approval in Japan for treatment of macular edema following CRVO

Regeneron Pharmaceuticals, Inc. today announced that EYLEA (aflibercept) Injection has received approval for the treatment of Macular Edema Following Central Retinal Vein Occlusion from the Japanese Ministry of Health, Labour and Welfare.

22 Nov 2013

First molecular test developed to detect eosinophilic esophagitis

Researchers at Cincinnati Children's Hospital Medical Center have developed the first molecular test to diagnose eosinophilic esophagitis, a chronic upper gastrointestinal disorder. The incidence of EoE has skyrocketed since it was first characterized two decades ago.

22 Nov 2013

Scientists hope to find new treatments for traumatic brain injury

In the most wide-reaching project of its kind, scientists at the University of Texas Medical Branch are expanding their research on traumatic brain injury, examining its progressive, chronic effects on the body in hopes of treating its immediate and long-term consequences. The project is funded by a three-year, $9 million grant from The Moody Foundation of Galveston.

22 Nov 2013

Inhibition of parvalbumin-expressing prefrontal interneurons triggers fear behaviours

Using an approach combining in vivo recordings and optogenetic manipulations in mice, the researchers succeeded in showing that the inhibition of parvalbumin-expressing prefrontal interneurons triggers a chain reaction resulting in fear behaviour. Conversely, activation of these parvalbumin interneurons significantly reduces fear responses in rodents.

22 Nov 2013

New targeted treatments for autism may be possible

Finding major new clues to the origins of autism, a Yale-led team of researchers has pinpointed which cell types and regions of the developing human brain are affected by gene mutations linked to autism. They report their findings in the Nov. 21 issue of the journal Cell.

22 Nov 2013

UT Arlington assistant professor develops computational model to predict epileptic seizure

A UT Arlington assistant engineering professor has developed a computational model that can more accurately predict when an epileptic seizure will occur next based on the patient's personalized medical information.

22 Nov 2013

New NIH grant to help Chicago Stroke Trials Consortium accelerate treatment for stroke

A new network dedicated to advancing research and therapies for stroke is forming in Chicago thanks to $2 million in grants from the National Institutes of Health. The Chicago Stroke Trials Consortium is a partnership among Northwestern Medicine, Ann & Robert H. Lurie Children's Hospital of Chicago, John H. Stroger Jr. Hospital, Loyola University Medical Center, Rehabilitation Institute of Chicago, Rush University Medical Center, and University of Chicago Medicine that will build an infrastructure to support clinical trials for stroke prevention, treatment and recovery. Northwestern University will be the regional coordinating center for the consortium and administer the project over the next five years.

22 Nov 2013

Targeting single enzyme in the obese could help prevent and treat diabetes

A single overactive enzyme worsens the two core defects of diabetes—impaired insulin sensitivity and overproduction of glucose—suggesting that a drug targeting the enzyme could help correct both at once, according to mouse studies done by researchers at Columbia University Medical Center. The findings were published today in the online edition of Cell Metabolism.

22 Nov 2013

Studies link hundreds of gene mutations in the brain to increased autism risk

Pity the poor autism researcher. Recent studies have linked hundreds of gene mutations scattered throughout the brain to increased autism risk. Where do you start?

22 Nov 2013

Medical Condition News

Scientists use RNAi technology to reveal genes responsible for treating Parkinson's disease

UT Dallas professor awarded $2.3 million NIH grant to continue prosthetics, orthotics research

CVD expert requests Mexican government to carry out mandatory screening for 18-year-olds

Sorin Group receives CE Mark approval for Solo Smart stentless aortic valve

EC approves INVOKANA (canagliflozin) medication for adults with type 2 diabetes mellitus

NEXAVAR tablets receive FDA approval for treatment of patients with thyroid cancer

Study highlights need for ongoing surveillance for melanoma survivors

Sinai Hospital reports results from Phase 2a trial of apo A-I infusion therapy CSL112

Genetic diagnostic test for inherited eye diseases now available from Mass. Eye and Ear

Mouse study highlights importance of microorganisms in optimal cancer treatment outcomes

Nanotechnology-based technique: A painless method for maintaining healthy blood sugar levels

EYLEA Injection gets approval in Japan for treatment of macular edema following CRVO

First molecular test developed to detect eosinophilic esophagitis

Scientists hope to find new treatments for traumatic brain injury

Inhibition of parvalbumin-expressing prefrontal interneurons triggers fear behaviours

New targeted treatments for autism may be possible

UT Arlington assistant professor develops computational model to predict epileptic seizure

New NIH grant to help Chicago Stroke Trials Consortium accelerate treatment for stroke

Targeting single enzyme in the obese could help prevent and treat diabetes

Studies link hundreds of gene mutations in the brain to increased autism risk

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News